GreenLight Biosciences Holdings PBC (GreenLight Biosciences Holdings PBC) Cash per Share : $0.21 (As of Mar. 2023)

View and export this data going back to 2022. Start your Free Trial

What is GreenLight Biosciences Holdings PBC Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). GreenLight Biosciences Holdings PBC's Cash per Share for the quarter that ended in Mar. 2023 was $0.21.

GreenLight Biosciences Holdings PBC Cash per Share Historical Data

The historical data trend for GreenLight Biosciences Holdings PBC's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GreenLight Biosciences Holdings PBC Cash per Share Chart

GreenLight Biosciences Holdings PBC Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Cash per Share

0.27

0.99

0.26

0.45

GreenLight Biosciences Holdings PBC Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Cash per Share	Get a 7-Day Free Trial							0.68	0.36	0.65	0.45	0.21

GreenLight Biosciences Holdings PBC Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

GreenLight Biosciences Holdings PBC's Cash per Share for the fiscal year that ended in Dec. 2022 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	68.097	/	151.59
	=	0.45

GreenLight Biosciences Holdings PBC's Cash per Share for the quarter that ended in Mar. 2023 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	32.35	/	151.68
	=	0.21

GreenLight Biosciences Holdings PBC (NAS:GRNA) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

GreenLight Biosciences Holdings PBC Cash per Share Related Terms

Thank you for viewing the detailed overview of GreenLight Biosciences Holdings PBC's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

GreenLight Biosciences Holdings PBC (GreenLight Biosciences Holdings PBC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GreenLight Biosciences Holdings PBC (NAS:GRNA) » Definitions » Cash per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Hartwell Avenue, Lexington, MA, USA, 02421

Website

https://www.greenlightbiosciences.com

GreenLight Biosciences Holdings PBC is a pre-commercial stage synthetic biology company with a proprietary cell-free ribonucleic acid production platform for the discovery, development, and commercialization of high-performing products to promote healthier plants, foods, and people. The company is developing RNA products for plant and life science applications to advance crop management, plant protection, animal health, vaccine development, and pandemic preparation.

Executives

Deval L Patrick	other: See Remarks	BAIN CAPITAL, LLC, 200 CLARENDON STREET, BOSTON MA 02116
Dennis A. Clarke	other: Member of 13D group owning 10%	6 FERNWAY TERRACE, WINCHESTER MA 01890
Cummings Foundation, Inc.	other: Member of 13D group owning 10%	200 WEST CUMMINGS PARK, WOBURN MA 01801
Eric Senior Anderson	other: Member of 13D group owning 10%	25 N HILL ROAD, WESTOVER MA 01886
Mls Capital Fund Ii Lp	other: See remarks	C/O MLSC II (GP) (LABUAN) LLP, ONE MARKET ST SUITE 3525, SAN FRANCISCO CA 94105
Chelt Trading Ltd	other: Member of 13D Group	C/O FOX HORAN & CAMERINI LLP, 885 3RD AVENUE, 17TH FLOOR, NEW YORK NY 10022
Highview Trust	other: Member of 13D Group	C/O FOX HORAN & CAMERINI LLP, 885 THIRD AVENUE, 17TH FLOOR, NEW YORK NY 10022
Montealegre Lacayo Jaime Javier	other: Member of 13D Group	APARTADO 15-1250, ESCAZU G2
Furneaux Capital Holdco, Llc	other: Member of 13D group	1 MARINA PARK DRIVE, BOSTON MA 02210
Lewis & Clark Plant Sciences Fund I, Lp	other: Member of 13D group	120 S. CENTRAL AVENUE, SUITE 1000, ST. LOUIS MO 63105
Lewis & Clark Ventures I, Lp	other: Member of 13D group	120 S. CENTRAL AVENUE, SUITE 1000, ST. LOUIS MO 63105
Matthew Allen Walker	director, 10 percent owner	C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC, 200 BOSTON AVENUE, SUITE 3100, MEDFORD MA 02155
Martha Schlicher	director	C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC, 200 BOSTON AVENUE, SUITE 3100, MEDFORD MA 02155
Marta Ortega-valle	other: Member of 10% owner group	C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC, 200 BOSTON AVENUE, SUITE 3100, MEDFORD MA 02155
Builders Vision, Llc	10 percent owner	110 NW 2ND STREET SUITE 300, BENTONVILLE AR 72712